Corvus Pharmaceuticals, Inc.

CRVSNASDAQHealthcare● Active

$11.11

$-0.01(-0.09%)

Market Cap$934244344

P/E Ratio—

52W High$26.95

52W Low$3.55

Avg Volume1.5M

Open$11.47

Beta0.84

Overview

Corvus Pharmaceuticals, Inc. (CRVS) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · CRVS · as of Mar 12, 2026

Latest filing snapshot

+6+19.35%vs prior year

Corvus Pharmaceuticals, Inc. (CRVS) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

Change (1Y)

Growth % (1Y)

+19.35%

Revenue / Employee

—

Net Income / Employee

$-413.1K

Market Cap

$940M

CRVS Employee Count

2016 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-12	2025-12-31	37	+6	+19.35%
2025-03-25	2024-12-31	31	+3	+10.71%
2024-03-19	2023-12-31	28	-1	-3.45%
2023-03-28	2022-12-31	29	+1	+3.57%
2022-03-10	2021-12-31	28	-14	-33.33%
2021-03-25	2020-12-31	42	-11	-20.75%
2020-03-09	2019-12-31	53	+4	+8.16%
2019-03-07	2018-12-31	49	-6	-10.91%
2018-03-01	2017-12-31	55	+11	+25.00%
2017-03-10	2016-12-31	44	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

AKBA

Akebia Therapeutics, Inc.

KalVista Pharmaceuticals, Inc.

Olema Pharmaceuticals, Inc.

96$874M #6

CRVS

Corvus Pharmaceuticals, Inc.YOU

37$940M #7

CMPX

Compass Therapeutics, Inc.

35$280M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · CRVS peer comparison

About CRVS employees

CRVS Employees · Headcount

Corvus Pharmaceuticals, Inc. (CRVS) employee data is sourced from the annual SEC 10-K filing. As of 2025, Corvus Pharmaceuticals, Inc. had 37 full-time employees globally. Full-time employees only. Global consolidated headcount.

Corvus Pharmaceuticals, Inc.'s workforce increased by 6 (19.35%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

CRVS Employees · 5 questions

As of the latest SEC 10-K filing (2025), Corvus Pharmaceuticals, Inc. had 37 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Corvus Pharmaceuticals, Inc. employee counthow many employees does Corvus Pharmaceuticals, Inc. haveCRVS total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-12